Neuromuscular Rehabilitation for ACL Injury Prevention in Athletes

No longer recruiting at 5 trial locations
NB
NS
Overseen ByNathan Schilaty, DC, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on preventing a second ACL injury in young athletes who have already experienced one. It tests various rehab methods to determine which best helps athletes return to sports safely without reinjury. Participants will join one of three groups: a standard physical therapy group, a minimal home exercise group, or a neuromuscular training group (also known as Neuromuscular Intervention) that includes specific exercises to correct movement issues. Athletes who have had an ACL injury within the last six months, play sports involving quick movements, and have not undergone knee surgery are well-suited for this trial. As an unphased trial, it offers athletes the chance to explore innovative rehabilitation methods that could enhance recovery and prevent future injuries.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this neuromuscular intervention is safe for athletes?

Research has shown that neuromuscular training safely and effectively reduces the risk of ACL injuries. Studies indicate that this training can lower the chance of lower body injuries by about 27%. It includes exercises that strengthen the core and hips, helping to correct movement problems that might cause injuries.

In previous trials, athletes who participated in neuromuscular training experienced fewer ACL injuries. The training was well-received, and no major safety issues were reported. This makes it a promising option for preventing repeat ACL injuries in athletes.12345

Why are researchers excited about this trial?

Researchers are excited about the neuromuscular rehabilitation technique because it focuses on correcting movement flaws that can lead to ACL injuries, which is a new approach compared to standard treatments that primarily emphasize strength, agility, and plyometric exercises. Unlike traditional methods, this innovative technique provides verbal and visual feedback during exercises to enhance core and hip strength, potentially reducing the risk of a second ACL injury. By incorporating neuromuscular training and single-leg drills, it targets specific weaknesses in movement patterns, offering a more personalized and dynamic rehabilitation strategy for athletes.

What evidence suggests that this trial's treatments could be effective for preventing a second ACL injury?

Studies have shown that neuromuscular training (NMT), which participants in the Intervention Group with Neuromuscular Training will receive, can effectively lower the risk of ACL injuries. For instance, NMT reduced the chance of an ACL injury from 1 in 54 to 1 in 111, nearly cutting the risk in half. Research also shows that NMT decreases the risk of lower body injuries by about 27%. This training includes exercises that strengthen the core and hips and correct movement problems, helping to prevent injuries during sports activities.36789

Who Is on the Research Team?

AJ

Aaron J Krych, MD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for active athletes aged between 14 and 24 who have had their first ACL injury within the last 6 months. They should not have had previous knee surgeries, complex meniscus tears, or other recent injuries that required medical care. Participants must have been involved in sports requiring cutting, jumping, or pivoting for at least 50 hours a year.

Inclusion Criteria

Pre-injury participation in cutting, jumping or pivoting sports for ≥ 50 hours/year
I haven't had a lower back or leg injury requiring medical care in the year before my ACL injury.
My knee is stable after an MCL injury and before surgery.
See 5 more

Exclusion Criteria

It has been over 6 months since I injured my ACL.
I injured my knee from a direct hit.
My knee is unstable due to an untreated MCL injury.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo different rehabilitation protocols including HOME, STAN, and TNMT over a six-week period

6 weeks
12 sessions (in-person) for STAN and TNMT groups

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of knee kinematics and kinetics

5 years

What Are the Treatments Tested in This Trial?

Interventions

  • Neuromuscular Intervention
Trial Overview The study aims to reduce second ACL injuries by identifying high-risk individuals based on movement patterns and testing different rehab protocols after initial ACL reconstruction. The interventions being tested are HOME (home-based exercises) and TNMT (targeted neuromuscular training).
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group with Neuromuscular TrainingExperimental Treatment1 Intervention
Group II: Control GroupExperimental Treatment1 Intervention
Group III: Standard of Care GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Trials
508
Recruited
1,090,000+

Published Research Related to This Trial

A systematic review of 14 studies found that longer durations and higher frequencies of neuromuscular training (NMT) significantly reduce the risk of ACL injuries in female athletes, with odds ratios indicating better outcomes for longer training sessions (OR 0.35) and multiple training sessions (OR 0.35).
The analysis revealed an inverse dose-response relationship, suggesting that as the volume of NMT increases, the effectiveness in preventing ACL injuries also increases, highlighting the importance of tailored training programs for optimal injury prevention.
Dosage effects of neuromuscular training intervention to reduce anterior cruciate ligament injuries in female athletes: meta- and sub-group analyses.Sugimoto, D., Myer, GD., Foss, KD., et al.[2022]
A neuromuscular training (NMT) program significantly improved hip biomechanics in athletes after anterior cruciate ligament (ACL) reconstruction, as evidenced by increased International Knee Documentation Committee (IKDC) scores and better landing mechanics after 12 training sessions.
Despite improvements in overall hip biomechanics, the specific hip abduction angle and external rotation moment did not show significant changes in the involved limbs, suggesting that while NMT can enhance control and reduce injury risk, further targeted interventions may be needed for specific biomechanical deficits.
Neuromuscular Training Improves Self-Reported Function and Single-Leg Landing Hip Biomechanics in Athletes After Anterior Cruciate Ligament Reconstruction.Nagelli, C., Di Stasi, S., Tatarski, R., et al.[2022]
In a study involving 547 female athletes across 52 teams, compliance with a neuromuscular training (NMT) program aimed at reducing knee injuries was found to be higher in the experimental group compared to the control group, with coaches in the experimental group showing significantly better compliance.
While nearly 90% of athletes completed at least two-thirds of the NMT sessions, coach compliance was notably higher at the high school level than at the middle school level, indicating a need for improved coach engagement in NMT interventions, especially for younger athletes.
Preventive Neuromuscular Training for Young Female Athletes: Comparison of Coach and Athlete Compliance Rates.Sugimoto, D., Mattacola, CG., Bush, HM., et al.[2018]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/30001501/
A Systematic Review and Meta-analysis - PubMed - NIHNMT reduced the risk for ACL injury from 1 in 54 to 1 in 111 (odds ratio [OR], 0.51; 95% CI, 0.37-0.69]). The overall mean training volume was 18.17 hours for ...
Effectiveness of Neuromuscular Training Based on the ...The hypotheses were that (1) TNMT would decrease biomechanical and neuromuscular factors related to an increased ACL injury risk and (2) TNMT would decrease ...
The preventive effects of neuromuscular training on lower ...Data from 24 included studies demonstrated that NMT reduced the overall risk of lower extremity injuries by 27 % (0.73, 95 % CI 0.67–0.79). Subgroup analyses by ...
Neuromuscular training to prevent ACL injuries in female ...In comparison to the control group, neuromuscular training reduced ACL injury odds (OR 0.81, 95% CI 0.70–0.94). A significant improvement in ...
Effective Anterior Cruciate Ligament Injury Prevention ...Neuromuscular training (NMT) programs have been effective in reducing ACL injury risk in athletic populations, though additional clarity on ...
Team Approach: Neuromuscular Training for Primary and ...Neuromuscular training has consistently been shown to reduce the risk of anterior cruciate ligament injury, particularly for athletes engaged in ...
Outcomes of a randomized controlled trial of neuromuscular ...The purpose of this study was to determine the effects of a randomized clinical trial to reduce a risk factor of ACL injuries, knee abduction moment (KAM),
Compliance With Neuromuscular Training and Anterior ...Higher rates of compliance with neuromuscular training programs were associated with lower rates of anterior cruciate ligament (ACL) injury incidence among ...
Neuromuscular Rehabilitation in the Prevention of Anterior ...This study aims to evaluate the effectiveness of neuromuscular training (NMT) programs in preventing ACL injuries in young populations.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security